<- Go Home
Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
Market Cap
$260.6M
Volume
84.2K
Cash and Equivalents
$1.4M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$10.85
52 Week Low
$9.95
Dividend
N/A
Price / Book Value
-38.49
Price / Earnings
35.75
Price / Tangible Book Value
-38.49
Enterprise Value
$259.2M
Enterprise Value / EBITDA
N/A
Operating Income
-$1.2M
Return on Equity
113.49%
Return on Assets
-0.38
Cash and Short Term Investments
$1.4M
Debt
$11.8K
Equity
-$6.8M
Revenue
N/A
Unlevered FCF
-$87.0K
Sector
Capital Markets
Category
N/A